CEVEC Pharmaceuticals GmbH, a biopharmaceutical company, engages in developing and producing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. The company was founded in 2001 and is based in Cologne, Germany.
Funding Rounds (2) - $14.03MUpdate
Current Team (4)Update
|Jul 25, 2011||FinSMEs - FinSMEs|
|Feb 2, 2010||OnBioVC - CEVEC Pharmaceuticals, GmbH: Series B $5.4MbyOnBioVC|